These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 35841520)

  • 1. Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease.
    Di Luca DG; Reyes NGD; Fox SH
    Drugs; 2022 Jul; 82(10):1027-1053. PubMed ID: 35841520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New dopaminergic therapies for PD motor complications.
    Larson D; Simuni T
    Neuropharmacology; 2022 Feb; 204():108869. PubMed ID: 34742740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New and emerging medical therapies in Parkinson's disease.
    Lotia M; Jankovic J
    Expert Opin Pharmacother; 2016; 17(7):895-909. PubMed ID: 26830844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levodopa, motor fluctuations and dyskinesia in Parkinson's disease.
    Müller T; Russ H
    Expert Opin Pharmacother; 2006 Sep; 7(13):1715-30. PubMed ID: 16925499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-dopaminergic treatments for motor control in Parkinson's disease.
    Fox SH
    Drugs; 2013 Sep; 73(13):1405-15. PubMed ID: 23917951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's disease.
    Antonini A; Chaudhuri KR; Martinez-Martin P; Odin P
    CNS Drugs; 2010 Feb; 24(2):119-29. PubMed ID: 20088619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and investigational non-dopaminergic agents for management of motor symptoms (including motor complications) in Parkinson's disease.
    Müller T
    Expert Opin Pharmacother; 2017 Oct; 18(14):1457-1465. PubMed ID: 28847181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New treatments for the motor symptoms of Parkinson's disease.
    Vijverman AC; Fox SH
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):761-77. PubMed ID: 25318835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Management and Prevention of Motor Complications in Parkinson's Disease.
    Aradi SD; Hauser RA
    Neurotherapeutics; 2020 Oct; 17(4):1339-1365. PubMed ID: 32761324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease - current treatment.
    Wang R; Shih LC
    Curr Opin Neurol; 2023 Aug; 36(4):302-308. PubMed ID: 37366218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications.
    Stowe R; Ives N; Clarke CE; Deane K; ; Wheatley K; Gray R; Handley K; Furmston A
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007166. PubMed ID: 20614454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
    Annic A; Devos D; Seguy D; Dujardin K; Destée A; Defebvre L
    Rev Neurol (Paris); 2009; 165(8-9):718-27. PubMed ID: 19150100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Update on Nondopaminergic Treatments for Motor and Non-motor Symptoms of Parkinson's Disease.
    Jing XZ; Yuan XZ; Luo X; Zhang SY; Wang XP
    Curr Neuropharmacol; 2023; 21(8):1806-1826. PubMed ID: 35193486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
    Rosqvist K; Horne M; Hagell P; Iwarsson S; Nilsson MH; Odin P
    J Parkinsons Dis; 2018; 8(1):59-70. PubMed ID: 29480220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Parkinson's disease in the advanced stage.
    Ossig C; Reichmann H
    J Neural Transm (Vienna); 2013 Apr; 120(4):523-9. PubMed ID: 23474822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa in the treatment of Parkinson's disease.
    Schapira AH; Emre M; Jenner P; Poewe W
    Eur J Neurol; 2009 Sep; 16(9):982-9. PubMed ID: 19538218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
    Jankovic J; Stacy M
    CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary Options for the Management of Motor Complications in Parkinson's Disease: Updated Clinical Review.
    Cabreira V; Soares-da-Silva P; Massano J
    Drugs; 2019 Apr; 79(6):593-608. PubMed ID: 30905034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor complications in Parkinson's disease: ten year follow-up study.
    López IC; Ruiz PJ; Del Pozo SV; Bernardos VS
    Mov Disord; 2010 Dec; 25(16):2735-9. PubMed ID: 20931632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there room for new non-dopaminergic treatments in Parkinson's disease?
    Pilleri M; Koutsikos K; Antonini A
    J Neural Transm (Vienna); 2013 Feb; 120(2):349-52. PubMed ID: 23229903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.